secwatch.observer — SEC 8-K summary
======================================

Issuer:     Clearside Biomedical, Inc. (CLSDQ)
CIK:        0001539029
Form:       8-K
Filed at:   2025-02-13T23:59:59+00:00
Accession:  0000950170-25-019866
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Clearside Biomedical receives Nasdaq minimum bid price deficiency notice
------------------------------------------------------------------------

- Notice received Feb 7, 2025; stock below $1.00 for 30 consecutive business days.
- Company has 180 days (until Aug 6, 2025) to regain compliance.
- To cure, bid price must close at $1.00+ for 10 consecutive business days.
- Options include transfer to Nasdaq Capital Market or reverse stock split.
- Failure to comply may result in delisting; company intends to monitor and seek remedies.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1539029/000095017025019866/0000950170-25-019866-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1539029/000095017025019866/clsd-20250207.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-019866

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer